Mount Sinai's $1M XPRIZE Bet: Can the Immune System Be Reset to Fight Aging?
Mount Sinai secured $1M in XPRIZE Healthspan funding to run NYC-Vita, a trial combining lifestyle and medication to restore immune function decades lost to aging.
Quest Diagnostics Is Now Selling Biological Age: What the $29 Test Actually Measures
Humanity's biological age test is now a $29 add-on at 2,000 Quest locations. The model behind it tracked 306,000+ people for 11.6 years and covers six body systems.
Can AI Put the Cell Back Together? GenBio's Virtual Cell Model Tries
GenBio AI's AIDO Cell system creates a stateful virtual cell model — integrating DNA, RNA, and protein behavior — to predict how intervention sequences affect biological aging.
Biological Age Clocks: The Regulatory Reckoning Is Coming
With $3.74 billion flowing into longevity biotech in Q1 2026 alone, investors are backing biological age diagnostics that regulators cannot yet validate. The collision between capital and clinical evidence is building.
Aging Research Has Been Studying the Wrong Sex
The Reproductive Resilience Hypothesis, published in Cell, argues female biology holds the key to understanding longevity — but most aging research has treated it as experimental noise.
Niagen's NR Study: A 2.5-Year Drop in Muscle Epigenetic Age
A new peer-reviewed analysis links NR supplementation to a 2.5-year reduction in muscle epigenetic age — though the funding company calls the data preliminary.
Scientists Reversed 'Permanent' Aging Damage in Human Tissue. Here's What Was Fixed.
A Nature Communications study showed an engineered enzyme (CMLase) removed advanced glycation end products from human arterial, skin, and lens tissue — reversing damage long considered irreversible.
SystemAge 2.1: The First Biological Age Test with Separate Male and Female Models
Generation Lab's SystemAge 2.1 analyzes 460+ biomarkers across 21 organ systems using gender-specific algorithms — the most granular biological age measurement now available through clinical partners.
Forever Chemicals Are Accelerating Your Biological Age — Longevity Needs to Catch Up
Two peer-reviewed studies link PFAS exposure to accelerated epigenetic aging via C-reactive protein. The longevity field's focus on what to add ignores what to remove — and that gap is measurable.
Glycans: The Aging Biomarker That Predicts Disease a Decade Early
IgG glycans explain 58% of age variance—more than telomeres—and predict cardiovascular events and diabetes onset up to 10 years early. Here's what that means.
Aging Clocks: What They Actually Measure (And Why Most Are Still Wrong)
Not all biological age clocks are equal. Learn why third-generation clocks like DunedinPACE outperform Horvath by orders of magnitude — and what to demand before paying for a test.
Peter Attia's AMA 81: Biological Age Tests, GLP-1s, and What Actually Moves the Needle
AMA 81 covers biological age clocks, GLP-1 receptor agonists, Zone 2 training, and sun exposure — a distillation of what biohacking evidence says is worth acting on in 2026.
Intrinsic Capacity: The New Benchmark for Biohacking Architecture
Analysis of the Stanford THRIVE coalition's push for measuring intrinsic capacity at scale and its implications for longevity protocols in 2026.